| 701 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
57 |
| 702 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 703 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 704 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
2 |
| 705 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 706 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
11 |
| 707 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
54 |
| 708 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
78 |
| 709 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
6 |
| 710 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
58 |
| 711 |
Cord Tissue |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Romania |
5 |
| 712 |
Cord Tissue |
Allogeneic – Related
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Romania |
5 |
| 713 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
4 |
| 714 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 715 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 716 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
25 |
| 717 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
6 |
| 718 |
Cord Tissue |
Allogeneic – Unrelated
|
Progressive bulbar palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
62 |
| 719 |
Cord Tissue |
Allogeneic – Unrelated
|
Encephalopathy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
67 |
| 720 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 721 |
Cord Tissue |
Allogeneic – Unrelated
|
Degenerative and traumatic cartilage damage
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
61 |
| 722 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 723 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
6 |
| 724 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
1 |
| 725 |
Cord Tissue |
Allogeneic – Unrelated
|
Myelitis
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
38 |
| 726 |
Cord Tissue |
Allogeneic – Unrelated
|
Anemia
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 727 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
6 |
| 728 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 729 |
Cord Tissue |
Allogeneic – Unrelated
|
Spinocerebellar Ataxia
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 730 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
1 |
| 731 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
1 |
| 732 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 733 |
Cord Tissue |
Allogeneic – Unrelated
|
Progressive bulbar palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
63 |
| 734 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
15 |
| 735 |
Cord Tissue |
Allogeneic – Unrelated
|
GvHD
|
Immunology
|
2025
|
Experimental Therapy |
Poland |
13 |
| 736 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
48 |
| 737 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
51 |
| 738 |
Cord Tissue |
Allogeneic – Unrelated
|
GvHD
|
Hematology
|
2025
|
Experimental Therapy |
Poland |
12 |
| 739 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
10 |
| 740 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
8 |
| 741 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 742 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Infarction
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
57 |
| 743 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 744 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebellar Syndrome
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
43 |
| 745 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
61 |
| 746 |
Cord Tissue |
Allogeneic – Unrelated
|
Cartilage Lesions
|
Orthopedics
|
2025
|
Experimental Therapy |
Poland |
57 |
| 747 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
1 |
| 748 |
Cord Tissue |
Allogeneic – Unrelated
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 749 |
Cord Tissue |
Allogeneic – Unrelated
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 750 |
Cord Blood |
Allogeneic – Related
|
Thalassemia Major
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
5 |
| 751 |
Cord Blood |
Autologous
|
Aplastic Anemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
2 |
| 752 |
Cord Blood |
Allogeneic – Related
|
Thalassemia Major
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
6 |
| 753 |
Cord Blood |
Allogeneic – Related
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Portugal |
1 |
| 754 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Romania |
5 |
| 755 |
Cord Blood |
Allogeneic
|
Acute lymphoblastic leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
13 |
| 756 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 757 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
7 |
| 758 |
Cord Blood |
Allogeneic
|
Thalassemia Major
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
10 |
| 759 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
4 |
| 760 |
Cord Blood |
Autologous
|
Cerebral Palsy
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 761 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 762 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
2 |
| 763 |
Cord Blood |
Autologous
|
Unbalanced AVSD
|
Cardiovascular
|
2025
|
Experimental Therapy |
Poland |
5 |
| 764 |
Cord Blood |
Allogeneic – Related
|
Relapsed Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
8 |
| 765 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
10 |
| 766 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 767 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
4 |
| 768 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 769 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
5 |
| 770 |
Cord Blood |
Autologous
|
Autism
|
Neurology
|
2025
|
Experimental Therapy |
Poland |
3 |
| 771 |
Cord Blood |
Allogeneic – Related
|
D57.1 Sickle Cell Anemia
|
Hematology
|
2025
|
Standard Therapy |
Turkey |
5 |
| 772 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
66 |
| 773 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
63 |
| 774 |
Bone Marrow Family |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2025
|
Standard Therapy |
Poland |
71 |
| 775 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
72 |
| 776 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
47 |
| 777 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Ukraine |
43 |
| 778 |
Bone Marrow Family |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
49 |
| 779 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
51 |
| 780 |
Bone Marrow Family |
Allogeneic
|
Philadelphia – positive Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
61 |
| 781 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
58 |
| 782 |
Bone Marrow Family |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2025
|
Standard Therapy |
NETHERLANDS |
63 |
| 783 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
65 |
| 784 |
Bone Marrow Family |
Allogeneic
|
Acute Lymphoblastic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
France |
63 |
| 785 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Poland |
68 |
| 786 |
Bone Marrow Family |
Allogeneic
|
Myelofibrosis
|
Hematology
|
2025
|
Standard Therapy |
France |
71 |
| 787 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Russia |
51 |
| 788 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
62 |
| 789 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Czechia |
54 |
| 790 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
16 |
| 791 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
USA |
61 |
| 792 |
Bone Marrow Family |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
61 |
| 793 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Italy |
70 |
| 794 |
Bone Marrow Family |
Allogeneic
|
PostET Myelofibrosis
|
Hematology
|
2025
|
Standard Therapy |
Netherlands |
21 |
| 795 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Poland |
68 |
| 796 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia/ Mielodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
Germany |
65 |
| 797 |
Bone Marrow Family |
Allogeneic
|
Acute Myelogenous Leukemia
|
Hematology
|
2025
|
Standard Therapy |
NETHERLANDS |
60 |
| 798 |
Bone Marrow Family |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2025
|
Standard Therapy |
USA |
33 |
| 799 |
Bone Marrow Family |
Allogeneic
|
Muscular Dystrophy Association
|
Hematology
|
2025
|
Standard Therapy |
United Kingdom |
75 |
| 800 |
Bone Marrow Family |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2025
|
Standard Therapy |
Germany |
72 |
Albánia
Bosznia Herzegovina
Bulgária
Horvátország
Ciprus
Montenegró
Cseh Köztársaság
Dánia
Észtország
Spanyolország
Koszovó
Litvánia
Lettország
Luxemburg
Macedónia
Németország
Lengyelország
Portugália
Románia
Szerbia
Szlovákia
Szlovénia
Svájc
Svédország
Törökország
Magyarország
Egyesült Királyság
Olaszország
UAE
Hong-Kong
Kuvait
Libanon
Dél-Afrika
